Academic cancer centers are facing severe staffing shortages after three years of personnel attrition during the COVID-19 pandemic—resulting in depressed levels of patient accrual to investigator-initiated and grant-funded clinical trials.
Delays in processing of U.S. visas are keeping foreign born resident physicians from joining U.S. residency programs, which began on July 1, a group of more than 20 medical societies said.
